Aurobindo Pharma Share Price Target & Stock Analysis (Sep 2026)
Zumedha Equity Research Research . Analysis . Insights CMP₹1,734 as on 18 Sep 2026 Fully Valued: Reduce on Strength Aurobindo Pharma Ltd: Stock Analysis and Share Price Target India’s largest...
Neuland Laboratories Valuation & Share Price Analysis Aug 2026
Zumedha Equity Research Research . Analysis . Insights CMP₹23,550 as on 27 Aug 2026 Priced for Perfection Neuland Laboratories (NEULANDLAB) A full stock analysis of Neuland Laboratories Ltd (NSE:...
Torrent Pharmaceuticals DCF Valuation and Share Price Analysis Aug 2026
Zumedha Equity Research Research . Analysis . Insights CMP ₹4,886 as on 24 Aug 2026 ACCUMULATE ON DIPS Torrent Pharmaceuticals Ltd India’s specialty branded-generics leader in Cardiovascular,...
Biocon Ltd DCF Valuation and Share Price Analysis Aug 2026
Zumedha Equity Research Research . Analysis . Insights CMP₹426 ₹426 (as on 07 Aug 2026) Hold / Accumulate on Dips Biocon Ltd India’s largest fully-integrated biopharmaceutical company —...
Granules India Share Price Valuation Analysis April 2026
Granules India — Zumedha Equity Research Zumedha Equity Research Initiating Coverage CMP ₹638 as on 17 Apr 2026 ACCUMULATE Granules India Ltd. Pharmaceuticals · Active Pharma Ingredients...
DIVI’S LAB Valuation Report April 2026
Divi’s Laboratories — Equity Research Report Zumedha Equity Research · India Pharmaceuticals — API & CDMO NSE: DIVISLAB | BSE: 53248807 April 2026 Divi’s Laboratories API...
Sun Pharmaceutical Industries Share Price Analysis April 2026
Sun Pharmaceutical Industries — Equity Research Report Zumedha Equity Research ◆ India Pharmaceuticals ◆ NSE: SUNPHARMA | BSE: 524715 31 Mar 2026 CMP ₹1,769 (as on 31 Mar 2026) 52W H/L...
Zydus Lifesciences Ltd Share Price Analysis April 2026
Zydus Lifesciences — Investment Research Report Zumedha Equity Research · Indian Pharma Sector NSE: ZYDUSLIFE | 31 March 2026 | Initiating Coverage CMP ₹872 as on 31 Mar 2026...
CIPLA Share Price Analysis April 2026
Cipla Ltd — Investment Research Report Zumedha Equity Research · Indian Listed Securities · Pharmaceuticals & Healthcare · 03 April 2026 NSE: CIPLA...
Laurus Labs — DCF analysis March 2026
Laurus Labs — Investment Research Report Zumedha Investment Research NSE: LAURUSLABS | BSE: 540222 29 March 2026 | Sector: Pharmaceuticals / CDMO LAURUSLABS CMP ₹984 52W Range...